放线菌酮A是从链霉菌中分离出来的,具有证明的针对幽门螺杆菌的活性,二者均具有较强的MIC(选择性)为0.0001 g / ml,并且具有选择性。历史上,该化合物最初被鉴定为对某些皮肤真菌和革兰氏阳性细菌具有弱活性,同时具有冠脉舒张活性。
Product description:
Actinopyrone A is isolated from Streptomyces sp|with documented activity against Helicobacter pylori|that is both potent, with an MIC 0.0001 g/ml, and selective. Historically the compound was originally identified for having weak activity against some dermatophytes and Gram-positive bacteria along with coronary vasodilating activity.
规格
英文别名
Compound NP-009131 | 4H-Pyran-4-one, 2-(10-hydroxy-3,7,9,11-tetramethyl-2,5,7,11-tridecatetraenyl)-6-methoxy-3,5-dimethyl- | SS 12538A | Actinopyrone A | 2-[(2E,5E,7E,11E)-10-hydroxy-3,7,9,11-tetramethyltrideca-2,5,7,11-tetraenyl]-6-methoxy-3,5-dimethylpyran-4-one